Molecular mechanisms regulating Th1 immune responses

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 713-758

  Szabo, Susanne J ^a   Sullivan, Brandon M ^a   Peng, Stanford L ^c   Glimcher, Laurie H ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Disease states; Signal transduction; Th1 cells; Transcription factors

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; GAMMA INTERFERON; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERELUKIN 18; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 4; JANUS KINASE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE P60; PROTEIN TYROSINE KINASE; STAT PROTEIN; STAT4 PROTEIN; SYNAPTOPHYSIN; T BOX TRANSCRIPTION FACTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR HLX; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR YY 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; CYTOKINE; INTERLEUKIN DERIVATIVE; LYMPHOCYTE ANTIGEN RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTING CELL; ASTHMA; ATOPY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL FATE; CELL LINEAGE; CELL MATURATION; CROHN DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; GENE EXPRESSION REGULATION; HASHIMOTO DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOCHEMISTRY; IN VITRO STUDY; LUPUS ERYTHEMATOSUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MACROPHAGE; MOLECULAR BIOLOGY; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STOCHASTIC MODEL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TRANSCRIPTION REGULATION; ULCERATIVE COLITIS; ANIMAL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CYTOLOGY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGEN-PRESENTING CELLS; ASTHMA; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CYTOKINES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKINS; MAP KINASE SIGNALING SYSTEM; MODELS, IMMUNOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; TH1 CELLS; TRANSCRIPTION FACTORS;

EID: 0038195719     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.140942     Document Type: Review

References (313)

1. O'Garra A, Arai N. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10:542-50
2. Glimcher LH, Murphy KM. 2000. Lineage commitment in the immune system: the T helper lymphocyte grows up. Gen. Dev. 14:1693-711
3. Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, et al. 2000. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18:451-94
4. Ho IC, Glimcher LH. 2002. Transcription: tantalizing times for T cells. Cell 109(Suppl.):S109-20
5. Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, et al. 2001. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19:23-45
6. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183-86
7. Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, et al. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96:1036-41
8. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587-92
9. + dendritic cells generate an immune response after subcutaneous injections without homing to the draining lymph node. J. Exp. Med. 189:593-98
10. Moser M, Murphy KM. 2000. Dendritic cell regulation of Th1-Th2 development. Nat. Immunol. 1:199-205
11. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, et al. 2000. Eta-1 (Osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287:860-64
12. + T cells. J. Exp. Med. 185:461-69
13. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. 2000. Control of Th2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404:407-11
14. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322
15. + T cell differentiation. J. Immunol. 159:5956-63
16. Sloan-Lancaster J, Steinberg TH, Allen PM. 1997. Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype. J. Immunol. 159:1160-68
17. Grakoui A, Donermeyer DL, Kanagawa O, Murphy KM, Allen PM. 1999. TCR-independent pathways mediate the effects of antigen dose and altered peptide ligands on Th cell polarization. J. Immunol. 162:1923-30
18. Galbiati F, Razani B, Lisanti MP. 2001. Emerging themes in lipid rafts and caveolae. Cell 106:403-11
19. Cherukuri A, Dykstra M, Pierce SK. 2001. Floating the raft hypothesis: lipid rafts play a role in immune cell activation. Immunology 14:657-60
20. Balamuth F, Leitenberg D, Unternaehrer J, Mellman I, Bottomly K. 2001. Distinct patterns of membrane microdomain partitioning in Th1 and Th2 cells. Immunology 15:729-38
21. Schaeffer EM, Schwartzberg PL. 2000. Tec family kinases in lymphocyte signaling and function. Curr. Opin. Immunol. 12:282-88
22. Miller AT, Berg LJ. 2002. New insights into the regulation and functions of Tec family tyrosine kinases in the immune system. Curr. Opin. Immunol. 14:331-40
23. Schaeffer EM, Debnath J, Yap G, McVicar D, Liao XC, et al. 1999. Requirement for tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284:638-41
24. Kashiwakura JI, Suzuki N, Nagafuchi H, Takeno M, Takeba Y, et al. 1999. Txk, a nonreceptor tyrosine kinase of the Tec family, is expressed in T helper type 1 cells and regulates interferon γ production in human T lymphocytes. J. Exp. Med. 190:1147-54
25. Debnath J, Chamorro M, Czar MJ, Schaeffer EM, Lenardo MJ, et al. 1999. rlk/FXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases. Mol. Cell Biol. 19:1498-507
26. Perez-Villar JJ, O'Day K, Hewgill DH, Nadler SG, Kanner SB. 2001. Nuclear localization of the tyrosine kinase Itk and interaction of its SH3 domain with karyopherin α (Rch1α). Int. Immunol. 13:1265-74
27. Takeba Y, Nagafuchi H, Takeno M, Kashiwakura J, Suzuki N. 2002. Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcription. J. Immunol. 168:2365-70
28. Rajogopal K, Sommers CL, Decker DC, Mitchell EO, Korthauer U, et al. 1999. RIBP, a novel Rlk/Fxk- and Itk-binding adaptor protein that regulates T cell activation. J. Exp. Med. 190:1657-68
29. + T cells. Immunity 11:399-409
30. Schaeffer EM, Yap GS, Lewis CM, Czar MJ, McVicar DW, et al. 2001. Mutation of tec family kinases alters T helper cell differentiation. Nat. Immunol. 2:1183-88
31. Dong C, Davis RJ, Flavell RA. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20:55-72
32. Li B, Yu H, Zheng WP, Voll R, Na S, et al. 2000. Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. Science 288:2219-22
33. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA. 1998. Defective T cell differentiation in the absence of Jnk1. Science 282:2092-95
34. Constant SL, Dong C, Yang DD, Wysk M, Davis RJ, Flavell RA. 2000. JNK1 is required for T cell-mediated immunity against Leishmania major infection. J. Immunol. 165:2671-76
35. 2-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1. Mol. Cell Biol. 20:5227-34
36. + T cells to Th1 cells requires MAP kinase JNK2. Immunity 9:575-85
37. Rincón M, Enslen H, Raingeaud J, Recht M, Zapton T, et al. 1998. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17:2817-29
38. Zhang S, Kaplan MH. 2000. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-gamma expression. J. Immunol. 165:1374-80
39. Lu B, Yu H, Chow C, Li B, Zheng W, et al. 2001. GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity 14:583-90
40. Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM. 2001. IL-18-stimulated GADD45β required in cytokine-induced, but not TCR-induced, IFN-γ production. Nat. Immunol. 2:157-64
41. Freeman GJ, Borriello F, Hodes RJ, Reiser H, Hathcock KS, et al. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907-9
42. Green JM, Noel PJ, Sperling AI, Walunas TL, Gray GS, et al. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501-8
43. Schweitzer AN, Borriello F, Wong RCK, Abbas AK, Sharpe AH. 1997. Role of costimulators in T cell differentiation. J. Immunol. 158:2713-22
44. Ling V, Wu PW, Finnerty HF, Bean KM, Spaulding V, et al. 2000. Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J. Immunol. 164:1653-57
45. Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, et al. 1999. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402:827-32
46. Dong H, Zhu G, Tamada K, Chen L. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 12:1365-69
47. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, et al. 1999. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397:263-66
48. Lane P. 2000. Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th) 1 and Th2 cells. J. Exp. Med. 191:201-5
49. Akiba H, Miyahira Y, Atsuta M, Takeda K, Nohara C, et al. 2000. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental Leishmaniasis. J. Exp. Med. 191:375-80
50. Murata T, Ishii N, Takano H, Miura S, Ndhlovu S, et al. 2000. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 1991:365-74
51. Salomon B, Bluestone JA. 1998. LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J. Immunol. 161:5138-42
52. Smits HH, de Jong EC, Schuitemaker JH, Geijtenbeek TB, van Kooyk Y, et al. 2002. Intercellular adhesion molecule-1/LFA-1 ligation favors human Th1 development. J. Immunol. 168:1710-16
53. Rottman JB, Smith T, Tonra JR, Ganley K, Bloom T, et al. 2001. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Immunol. 2:605-11
54. Ozkaynak E, Gao W, Shemmeri N, Wang C, Gutierrez-Ramos JC, et al. 2001. Importance of ICOS-B7RP-I costimulation in acute and chronic allograft rejection. Nat. Immunol. 2:591-96
55. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, et al. 2001. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat. Immunol. 2:269-74
56. Munder M, Mallo M, Eichmann K, Modolell M. 1998. Murine macriphages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187:2103-8
57. + lymphoid dendritic cells. J. Exp. Med. 189:1981-86
58. Fukao T, Matsuda S, Koyasu S. 2000. Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells. J. Immunol. 164:64-71
59. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. 2001. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14:205-15
60. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S-I, et al. 1998. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J. Immunol. 161:3400-7
61. Boehm U, Klamp T, Groot M, Howard JC. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-95
62. Bach EA, Aguet M, Schreiber RD. 1997. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563-91
63. Leonard WJ, O'Shea JJ. 1998. JAKs and STATs: biological implications. Annu. Rev. Immunol. 16:293-322
64. Meraz MA, White M, Sheehan KCF, Bach EA, Rodig SJ, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-42
65. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, et al. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742-45
66. Dalton DK, Pitts-Meek S, Keshav S, Fi-gari IS, Bradley A, Stewart TA. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-42S
67. Durbin JE, Hackenmiller R, Simon MC, Levy DE. 1996. Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease. Cell 84:443-50
68. Cooper A, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-47
69. Kamijo R, Le J, Shapiro D, Havell EA, Huang S, et al. 1993. Mice that lack the interferon-g receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178:1435-40
70. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, et al. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941-49
71. Jouanguy E, Lamhamedi-Cherradi S, Lammas DA, Dorman S, Fondaneche MC, et al. 1999. A human IFNgR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21:370-80
72. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, et al. 1996. Interferon-γ-receptor deficiency in an infant with Fatal Bacille Calmette-Guerin infection. N. Engl. J. Med. 335:1956-61
73. Pierre-Audigier C, Jouanguy E, Lamhamedi S, Altare F, Rauzier J, et al. 1997. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin. Infect. Dis. 24:982-84
74. Scott P. 1991. IFN-γ modulates the early development of Th1 and Th2 response in a murine model of cutaneous Leishmaniasis. J. Immunol. 147:3149-55
75. Reiner SL, Locksley RM. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-77
76. Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV, Nacy CA. 1989. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143:266-74
77. Wang Z-E, Reiner SL, Zheng S, Dalton DK, Locksley RM. 1994. CD4+ effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J. Exp. Med. 179:1367-71
78. + T cell response. J. Exp. Med. 181:961-71
79. Bradley LM, Dalton DK, Croft M. 1996. A direct role for IFN-gamma in regulation of Th1 cell development. J. Immunol. 157:1350-58
80. Lu B, Ebensperger C, Dembic Z, Wang Y, Kvatyuk M, et al. 1998. Targeted disruption of the interferon-γ receptor 2 gene results in severe immune defects in mice. Proc. Natl. Acad. Sci. USA 95:8233-28
81. Smeltz RB, Chen J, Ehrhardt R, Shevach EM. 2002. Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression. J. Immunol. 168:6165-72
82. Hsieh C-S, Macatonia SE, O'Garra A, Murphy KM. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713-21
83. Launois P, Swihart KG, Milon G, Louis JA. 1997. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158:3317-24
84. + T cells from αβ-TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent. Int. Immunol. 5:1119-28
85. Wenner CA, Guler ML, Macatonia SE, O'Garra A, Murphy KM. 1996. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J. Immunol. 156:1442-47
86. Szabo SJ, Dighe AS, Gubler U, Murphy K. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185(5):817-24
87. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, et al. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825-31
88. Heath VL, Showe L, Crain C, Barrat FJ, Trinchieri G, O'Garra A. 2000. Ectopic expression of the IL-12 receptor-b2 in developing and committed Th2 cells does not affect the production of IL-4 or induce the production of IFN-γ. J. Immunol. 164:2861-65
89. Nishikomori R, Ehrhardt RO, Strober W. 2000. T helper type 2 cell differentiation occurs in the presence of interleukin 12 receptor β2 chain expression and signaling. J. Exp. Med. 191:847-58
90. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM. 1993. Pathogen-induced Th1 phenotype development in CD4+ alpha beta-TCR transgenic T cells is macrophage dependent. Int. Immunol. 5:371-82
91. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-49
92. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc. Natl. Acad. Science USA 90:10188-92
93. Manetti R, Parronchi P, Giudizi MG, Piccinni M-P, Maggi E, et al. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199-209
94. Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, et al. 1994. Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J. Exp. Med. 179:1273-83
95. Kato T, Hakamada R, Yamane H, Nariuchi H. 1996. Induction of Il-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J. Immunol. 156:3932-38
96. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, et al. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741-46
97. Ma X, Chow JM, Gri G, Carra G, Gerosa F, et al. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183:147-57
98. Schulz O, Edwards AD, Schito M, Aliberti J, Manickasingham S, et al. 2000. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13:453-62
99. Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, et al. 1994. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153:128-36
100. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, et al. 1996. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93:14002-7
101. Valiante NM, Rengaraju M, Trinchieri G. 1992. Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of B cell lines to stimulate T and NK cell proliferation. Cell Immunol. 145:187-98
102. Gately MK, Renzetti LM, Magram J, Stem AS, Adorini L, et al. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495-521
103. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, et al. 1995. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 181:1755-62
104. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168:5699-708
105. Bacon CM, Petricoin EFI, Ortaldo JR, Rees RC, Larner AC, et al. 1995. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 92:7307-11
106. Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, et al. 1996. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 157:4781-89
107. Rogge L, D'Ambrosio D, Biffi M, Penna G, Minetti LJ, et al. 1998. The role of Stat4 in species-specific regulation of Th cell development by type I IFN's. J. Immunol. 161:6567-74
108. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-25
109. Wu CY, Wang X, Gadina M, O'Shea JJ, Presky DH, Magram J. 2000. IL-12 receptor β2 (IL-12Rβ2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J. Immunol. 165:6221-28
110. Wu C, Ferrante J, Gately MK, Magram J. 1997. Characterization of IL-12 receptor beta1 chain (IL-12Rbeta1)-deficient mice: IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor. J. Immunol. 159:1658-65
111. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu C, et al. 1996. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity 4:471-81
112. Kaplan MH, Sun YL, Hoey T, Grusby MJ. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174-77
113. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, et al. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171-74
114. Cooper AM, Magram J, Ferrante J, Orme IM. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J. Exp. Med. 186:39-45
115. Altare F, Lammas DA, Jouanguy E, Revy P, Drysdale P, et al. 1998. Inherited interleukin 12 deficiency is associated with increased susceptibility to intracellular pathogens. J. Clin. Invest. 102:2035-40
116. Altare F, Durandy A, Lammas D, Emile JF, Jouanguy E, et al. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-35
117. de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, et al. 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435-38
118. Gollob JA, Veenstra KG, Jyonouchi H, Kelly AM, Ferrieri P, et al. 2000. Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and Staphylococcal infections. J. Immunol. 165:4120-26
119. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, et al. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292:1907-10
120. Kaplan MH, Wurster AL, Grusby MJ. 1998. A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J. Exp. Med. 188:1191-96
121. Schijns VE, Haagmans BL, Wierda CM, Kruithof B, Heijnen IA, et al. 1998. Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 160:3958-64
122. Oxenius A, Karrer U, Zinkernagel RM, Hengartner H. 1999. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J. Immunol. 162:965-73
123. Brombacher F, Dorfmuller A, Magram J, Dai WJ, Kohler G, et al. 1999. IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int. Immunol. 11:325-32
124. Magram J, Sfarra J, Connaughton S, Faherty D, Warrier R, et al. 1996. IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Annu. NY Acad. Sci. 795:60-70
125. Jankovic D, Kullberg MC, Hieny S, Caspar P, Collazo CM, Sher A. 2002. In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting. Immunity 16:429-39
126. Park AY, Hondowicz BD, Scott P. 2000. IL-12 is required to maintain a Th1 response during Leishmania major infection. J. Immunol. 165:896-902
127. Stobie L, Gurunathan S, Prussin C, Sacks DL, Glaichenhaus N, et al. 2000. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to mediate protection to an infectious parasite challenge. Proc. Natl. Acad. Sci. USA 97:8427-32
128. Yap G, Pesin M, Sher A. 2000. Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165:628-31
129. Sareneva T, Julkunen I, Matikainen S. 2000. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J. Immunol. 165:1933-38
130. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-50
131. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443-46
132. Matsumoto S, Tsuji-Takayama K, Aizawa K, Koide K, Takeuchi M, et al. 1997. Interleukin-18 activates NF-kappaB in murine T helper type 1 cells. Biochem. Biophys. Res. Comm. 234:454-57
133. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, et al. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7:571-81
134. Kojima H, Takeuchi M, Ohta T, Nishida Y, Arai N, et al. 1998. Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. Biochem. Biophys. Res. Comm. 244:183-86
135. Kanakaraj P, Ngo K, Wu Y, Angulo A, Ghazal P, et al. 1999. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J. Exp. Med. 189:1129-38
136. +T lymphocytes. J. Immunol. 160:3642-47
137. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, et al. 1996. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-2 for interferon-gamma production. Eur. J. Immunol. 26:1647-51
138. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, et al. 1997. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158:1541-50
139. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, et al. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383-90
140. + T cells. Immunity 16:779-90
141. Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, et al. 1996. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70:1143-53
142. Devergne O, Coulomb-L'Hermine A, Capel F, Moussa M, Capron F. 2001. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am. J. Pathol. 159:1763-76
143. Sprecher CA, Grant FJ, Baumgartner JW, Presnell SR, Schrader SK, et al. 1998. Cloning and characterization of a novel class I cytokine receptor. Biochem. Biophys. Res. Comm. 246:82-90
144. Chen Q, Ghilardi N, Wang H, Baker T, Xie MH, et al. 2000. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407:916-20
145. Yoshida H, Hamano S, Senaldi G, Covey T, Faggioni R, et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15:569-78
146. Farrar JD, Asnagli H, Murphy KM. 2002. T helper subset development: roles for instruction, selection, and transcription. J. Clin. Invest. 4:431-35
147. Smale ST, Fisher AG. 2002. Chromatin structure and gene regulation in the immune system. Annu. Rev. Immunol. 20:427-62
148. Agarwal S, Viola JPB, Rao A. 1999. Chromatin-based regulatory mechanisms governing cytokine gene transcription. J. Allergy Clin. Immunol. 103:990-99
149. Young HA, Ghosh P, Ye J, Lederer J, Lichtman A, et al. 1994. Differentiation of the T helper phenotypes by analysis of methylation state of the IFN-γ gene. J. Immunol. 153:3603-10
150. Zhu H, Yang J, Murphy TL, Ouyang W, Wagner F, et al. 2001. Unexpected characteristics of the IFN-γ reporters in nontransformed T cells. J. Immunol. 167:855-65
151. Agarwal S, Rao A. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9:765-75
152. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655-69
153. Zhang WX, Yang SY. 2000. Cloning and characterization of a new member of the T-box gene family. Genomics 70:41-48
154. Smith J. 1997. Brachyury and the T-box genes. Curr. Opin. Genet. Devel. 7:474-80
155. Papaioannou VE. 1997. T-box family reunion. Trends Genet. 13(6):212-13
156. Rodriguez-Esteban C, Tsukui T, Yonei S, Magallon J, Tamura K, Belmonte JCI. 1999. The T-box genes Tbx4 and Tbx5 regulate limb outgrowth and identity. Nature 398:814-8
157. Takeuchi JK, Koshiba-Takeuchi K, Matsumoto K, Vogel-Hopker A, Naitoh-Matsuo M, et al. 1999. Tbx5 and Tbx4 genes determine the wing/leg identity of limb buds. Naure 398:810-13
158. Bamshad M, Lin RC, Law DJ, Watkins WC, Krakowiak PA, et al. 1997. Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat. Genet. 16(3):311-15
159. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, et al. 1997. Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat. Genet. 15:30
160. Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis ARJ, et al. 1997. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat. Genet. 15:21-29
161. Spranger S, Ulmer H, Troger J, Jansen O, Graf J, et al. 1997. Muscular involvement in the Holt-Oram syndrome. J. Med. Genet. 34(12):978-81
162. Lighvani AA, Frucht DM, Jankovic D, Yamane H, Aliberti J, et al. 2001. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98:15137-42
163. + T cells. Nat. Immunol. 3:549-57
164. Mullen AC, Hutchins AS, High FA, Lee HW, Sykes KJ, et al. 2002. Hlx is induced by and genetically interacts with T-bet to promote heritable Th1 gene induction. Nat. Immunol. 10:652-58
165. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. 2002. Distinct effects of T-bet in Th1 lineage commitment and IFN-γ, production in CD4 and CD8 T cells. Science 295:338-42
166. Finotto S, Neurath MF, Glickman IN, Qin S, Lehr HA, et al. 2002. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295:336-38
167. Mullen AC, Hutchins AS, Villarino AV, Lee HW, High FA, et al. 2001. Cell cycle controlling the silencing and functioning of mammalian activators. Curr. Biol. 11:1695-99
168. Xu X, Sun YL, Hoey T. 1996. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273:794-96
169. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, et al. 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 383:344-47
170. Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, et al. 1998. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279:703-7
171. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell JEJ. 1996. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc. Natl. Acad. Sci. USA 93:15092-96
172. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29:548-55
173. Ouyang W, Jacobson NG, Bhattacharya D, Gorham JD, Fenoglio D, et al. 1999. The Ets transcription factor ERM is Th1-specific and induced by IL-12
174. Coccia EM, Passini N, Battistini A, Pini C, Sinigaglia F, Rogge L. 1999. Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells. J. Biol. Chem. 274:6698-703
175. Galon J, Sudarshan C, Ito S, Finbloom D, O'Shea JJ. 1999. IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells. J. Immunol. 162:7256-62
176. Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, et al. 1997. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6:673-79
177. Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, et al. 1997. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6(6):681-89
178. +T cells secreting Th1 or Th2 cytokines. Immunity 2:271-79
179. Croft M, Carter L, Swain SL, Dutton RW. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715-28
180. Carter LL, Murphy KM. 1999. Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon γ production from CD4+ versus CD8+ T cells. J. Exp. Med. 189:1355-60
181. Carding SR, Egan PJ. 2002. Gammadelta T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2:336-45
182. Yin Z, Zhang DH, Welte T, Bahtiyar G, Jung S, et al. 2000. Dominance of IL-12 over IL-4 in γδ T cell differentiation leads to default production of IFN-γ: failure to down-regulate IL-12 receptor β2-chain expression. J. Immunol. 164:3056-64
183. Yin Z, Chen CH, Szabo SJ, Glimcher LH, Ray A, Craft J. 2002. T-bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-g by gd T cells1. J. Immunol. 168:1566-71
184. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220
185. Glas R, Franksson L, Une C, Eloranta ML, Ohlen C, et al. 2000. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J. Exp. Med. 191:129-38
186. Barton K, Muthusamy N, Fischer C, Ting C-N, Walunas TL, et al. 1998. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9:555-63
187. DiMarzio P, Puddu P, Conti L, Belardelli F, Gessani S. 1994. Interferon gamma upregulates its own gene expression in mouse peritoneal macrophages. J. Exp. Med. 179:1731-36
188. Frucht DM, Fukao T, Bogdan C, Schindler H, O'Shea JJ, Koyasu S. 2001. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 22:556-60
189. Stober D, Schirmbeck R, Reimann J. 2001. IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells. J. Immunol. 167:957-65
190. Puddu P, Fantuzzi L, Borghi P, Varano B, Rainaldi G, et al. 1997. IL-12 induces IFN-γ expression and secretion in mouse peritoneal macrophages. J. Immunol. 159:3490-97
191. Fantuzzi L, Puddu P, Varano B, Del Corno M, Belardelli F, Gessani S. 2000. IFN-alpha and IL-18 exert opposite regulatory effects on the IL-12 receptor expression and IL-12-induced IFN-gamma production in mouse macrophages: novel pathways in the regulation of the inflammatory response of macrophages. J. Leukoc. Biol. 68:707-14
192. Frucht DM, Aringer M, Galon J, Danning C, Brown M, et al. 2000. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J. Immunol. 164:4659-64
193. Nagayama H, Sato K, Kawasaki H, Enomoto M, Morimoto C, et al. 2000. IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells. J. Immunol. 165:59-66
194. Grohmann U, Belladonna ML, Bianchi R, Orabona C, Ayroldi E, et al. 1998. IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production. Immunity 9:315-23
195. Schindler H, Lutz MB, Rollinghoff M, Bogdan C. 2001. The production of IFN-γ by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J. Immunol. 166:3075-82
196. Fukao T, Frucht DM, Yap G, Gadina M, O'Shea JJ, Koyasu S. 2001. Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J. Immunol. 166:4446-55
197. Snapper CM, Paul WE. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-47
198. Snapper CM, Peschel C, Paul WE. 1988. IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140:2121-27
199. Flaishon L, Hershkoviz R, Lantner F, Lider O, Alon R, et al 2000. Autocrine secretion of interferon γ negatively regulates homing of immature B cells. J. Exp. Med. 192:1381-87
200. Johnson-Leger C, Hasbold J, Holman M, Klaus GG. 1997. The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice. J. Immunol. 159:1150-59
201. Abed NS, Chace JH, Cowdery JS. 1994. T cell-independent and T cell-dependent B cell activation increases IFN-gamma R expression and renders B cells sensitive to IFN-gamma-mediated inhibition. J. Immunol. 153:3369-77
202. Hasbold J, Hong JS, Kehry MR, Hodgkin PD. 1999. Integrating signals from IFN-gamma and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a. J. Immunol. 163:4175-81
203. Snapper CM, Rosas F, Moorman MA, Jin L, Shanebeck K, et al. 1996. IFN-gamma is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway. Int. Immunol. 8:877-85
204. Peng SL, Szabo SJ, Glimcher LH. 2002. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. USA 99:5545-50
205. Lederer JA, Perez VL, DesRoches L, Kim SM, Abbas AK, Lichtman AH. 1996. Cytokine transcriptional events during helper T cell subset differentiation. J. Exp. Med. 184:397-406
206. Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, et al. 1998. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 95:625-36
207. Kamogawa Y, Minasi LE, Carding SR, Bottomly K, Flavell RA. 1993. The relationship of IL-4- and IFNγ-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75:985-95
208. + T cells. J. Immunol. 158:1085-94
209. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, et al. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292:1907-10
210. Ouyang W, Lohning M, Gao Z, Assenmacher M, Ranganath S, et al. 2000. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12:27-37
211. Lee HJ, Takemoto N, Kurata H, Kamogawa Y, Miyatake S, et al. 2000. GATA-3 induces Th2 cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 192:105-15
212. Mountford AP, Coulson PS, Cheever AW, Sher A, Wilson RA, Wynn TA. 1999. Interleukin-12 can directly induce T-helper 1 responses in interferon-gamma (IFN-gamma) receptor-deficient mice, but requires IFN-gamma signalling to downregulate T-helper 2 responses. Immunology 97:588-94
213. Neurath MF, Weigmann B, Finotto S, Hildner K, Glickman J, et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195:1129-43
214. Huang H, Paul WE. 1998. Impaired interleukin 4 signaling in T helper type 1 cells. J. Exp. Med. 187(8): 1305-13
215. Zheng W-P, Flavell RA. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587-96
216. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, et al. 1998. Inhibition of Th1 developmental mediated by GATA-3 through an IL-4 independent mechanism. Immunity 9:745-55
217. Kurata H, Lee HJ, O'Garra A, Arai N. 1999. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11:677-88
218. Rodriguez-Palmero M, Hara T, Thumbs A, Hunig T. 1999. Triggering of T cell proliferation through CD28 induces GATA-3 and promotes T helper type 2 differentiation in vitro and in vivo. Eur. J. Immunol. 29:3914-24
219. Ferber IA, Lee HJ, Zonin F, Heath V, Mui A, Arai N, O'Garra A. 1999. GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Cli. Immunol. 91:134-44
220. Reiner SL, Seder RA. 1999. Dealing from the evolutionary pawnshop: how lymphocytes make decisions. Immunity 11:1-10
221. Coffman RL, Reiner SL. 1999. Instruction, selection, or tampering with the odds? Science 284:1283
222. + T-cell phenotype development. Proc. Natl. Acad. Sci. USA 92:7565-69
223. Openshaw P, Murphy EE, Hosken NA, Maino V, Davis K, et al. 1995. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1357-67
224. + T cells activated in a T helper type-2 like response in vivo. Eur. J. Immunol. 5:1168-75
225. + T cells from alpha beta T cell receptor-transgenic mice: a distinct mucosal cytokine phenotype in the absence of transgene-specific antigen. Eur. J. Immunol. 27:1774-81
226. + T cell populations. Int. Immunol. 4:617-21
227. Hollander GA, Zuklys S, Morel C, Mizoguchi E, Mobisson K, et al. 1998. Monoallelic expression of the interleukin-2 locus. Science 279:2118-21
228. Riviere I, Sunshine MJ, Littman DR. 1998. Regulation of IL-4 expression by activation of individual alleles. Immunity 9:217-28
229. Bix M, Locksley RM. 1998. Independent and epigenetic regulation of the interleukin-4 alleles in CD4+ T cells. Science 281:1352-54
230. Hu-Li J, Pannetier C, Guo L, Lohning M, Gu H, et al. 2001. Regulation of expression of IL-4 alleles: analysis using a chimeric GFP/IL-4 gene. Immunity 4:1-11
231. Naramura M, Hu RJ, Gu H. 1998. Mice with a fluorescent marker for interleukin 2 gene activation. Immunity 9:209-16
232. Mohrs M, Shinkai K, Mohrs K, Locksley RM. 2001. Analysis of type 2 immunity in vivo with a bicistronic il-4 reporter. Immunity 15:303-11
233. Avni O, Rao A. 2000. T cell differentiation: a mechanistic view. Curr. Opin. Immunol. 12:654-59
234. Huang H, Hu-Li J, Chen H, Ben-Sasson SZ, Paul WE. 1997. IL-4 and IL-13 production in differentiated T helper type 2 cells is not IL-4 dependent. J. Immunol. 159:3731-38
235. Scully KM, Rosenfeld MG. 2002. Pituitary development: regulatory codes in mammalian organogenesis. Science 295:2231-35
236. Perry RL, Rudnick MA. 2000. Molecular mechanisms regulating myogenic determination and differentiation. Front. BioSci. 5:D750-67
237. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, et al. 1995. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11:40-44
238. Ting CN, Olson MC, Barton KP, Leiden JM. 1996. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384:474-78
239. Del Prete G. 1998. The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int. Rev. Immunol. 16:427-55
240. Robinson DS. 2000. Th-2 cytokines in allergic disease. Br. Med. Bull. 56:956-68
241. Ray A, Cohn L. 1999. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J. Clin. Invest. 104:985-93
242. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. 2001. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2:45-50
243. Neurath MF, Finotto S, Glimcher LH. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8:567-73
244. Nakamura Y, Ghaffar O, Olivenstein R, Taha RA, Soussi-Gounni A, et al. 1999. Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J. Allergy Clin. Immunol. 103:215-22
245. Caramori G, Lim S, Ito K, Tomita K, Oates T, et al. 2001. Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies. Eur. Respir. J. 18:466-73
246. Christodoulopoulos P, Cameron L, Nakamura Y, Lemiere C, Muro S, et al. 2001. TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression. J. Allergy Clin. Immunol. 107:586-91
247. Panina-Bordignon P, Papi A, Mariani M, Di Lucia P, Casoni G, et al. 2001. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J. Clin. Invest. 107:1357-64
248. Zhang DH, Yang L, Cohn L, Parkyn L, Homer R, et al. 1999. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11:473-82
249. Finotto S, De Sanctis GT, Lehr HA, Herz U, Buerke M, et al. 2001. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J. Exp. Med. 193:1247-60
250. Busse WW, Lemanske RF Jr. 2001. Asthma. N. Engl. J. Med. 344:350-62
251. Randolph DA, Carruthers CJL, Szabo SJ, Murphy KM, Chaplin DD. 1999. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J. Immunol. 162:2375-83
252. Randolph DA, Stephens R, Carruthers CJL, Chaplin DD. 1999. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J. Clin. Invest. 104:1021-29
253. Hansen G, Berry G, DeKruyff RH, Umetsu DT. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103:175-83
254. Li L, Xia Y, Nguyen A, Feng L, Lo D. 1998. Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J. Immunol. 161:3128-35
255. Cohn L, Homer RJ, Niu N, Bottomly K. 1999. T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J. Exp. Med. 190:1309-18
256. Sampath D, Castro M, Look DC, Holtzman MJ. 1999. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. J. Clin. Invest. 103:1353-61
257. Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, et al. 2002. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J.Immunol. 168:5278-86
258. Ford JG, Rennick D, Donaldson DD, Venkayya R, McArthur C, et al. 2001. IL-13 and IFN-γ: interactions in lung inflammation. J. Immunol. 167:1769-77
259. Shanahan F. 2002. Crohn's disease. Lancet 359:62-69
260. Farrell RJ, Peppercorn MA. 2002. Ulcerative colitis. Lancet 359:331-40
261. Sartor RB. 1997. Review article: How relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? Aliment Pharmacol. Ther. 11(Suppl. 3):89-96
262. Rogler G, Andus T. 1998. Cytokines in inflammatory bowel disease. World J. Surg. 22:382-89
263. Bhan AK, Mizoguchi E, Smith RN, Mizoguchi A. 1999. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol. Rev. 169:195-207
264. + T cells. Immunity 1:553-62
265. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. 1993. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology. 78:127-31
266. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157:1261-70
267. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, et al. 1997. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N. Engl. J. Med. 337:1029-35
268. Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, et al. 1997. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J. Immunol. 159:6276-82
269. Kosiewicz MM, Nast CC, Krishnan A, Rivera-Nieves J, Moskaluk CA, et al. 2001. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J. Clin. Invest. 107:695-702
270. Hasegawa SL, Riley JL, Sloan JH, Boss JM. 1993. Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells. J. Immunol. 150:1781-93
271. Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, et al. 1998. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J. Exp. Med. 187:1225-34
272. Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, Rennick DM. 1998. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 161:3143-9
273. Fuss IJ, Marth T, Neurath MF, Pearlstein GR, Jain A, Strober W. 1999. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterol. 117:1078-88
274. + T cells that respond to bacterial antigens. J. Immunol. 162:1884-88
275. Parrello T, Monteleone G, Cucchiara S, Monteleone I, Sebkova L, et al. 2000. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J. Immunol. 165:7234-39
276. Wiekowski MT, Leach MW, Evans EW, Sullivan L, Chen SC, et al. 2001. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166:7563-70
277. Wirtz S, Becker C, Blumberg R, Galle PR, Neurath MF. 2002. Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. J. Immunol. 168:411-20
278. Corbaz A, ten Hove T, Herren S, Graber P, Schwartsburd B, et al. 2002. IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease. J. Immunol. 168:3608-16
279. ten Hove T, Corbaz A, Amitai H, Aloni S, Belzer I, et al. 2001. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. Gastroenterol. 121:1372-79
280. Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, et al. 2001. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R1264-73
281. Kanai T, Watanabe M, Okazawa A, Sato T, Yamazaki M, et al. 2001. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterol. 121:875-88
282. Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF Jr., et al. 1999. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J. Immunol. 162:6829-35
283. Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, et al. 1999. Bioactive IL-18 expression is up-regulated in Crohn's disease. J. Immunol. 163:143-47
284. Clavell M, Correa-Gracian H, Liu Z, Craver R, Brown R, et al. 2000. Detection of interferon regulatory factor-1 in lamina propria mononuclear cells in Crohn's disease. J. Pediatr. Gastroenterol. Nutr. 30:43-47
285. Monteleone I, Vavassori P, Biancone L, Monteleone G, Pallone F. 2002. Immunoregulation in the gut: success and failures in human disease. Gut 50(Suppl. 3):III60-4
286. Brown M, Hu-Li J, Paul WE. 1988. IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism. J. Immunol. 131:504-11
287. Kitani A, Fuss IJ, Nakamura K, Schwartz OM, Usui T, Strober W. 2000. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-β1 plasmid: TGF-b1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor β2 chain downregulation. J. Exp. Med. 192:41-52
288. + T cells. J. Exp. Med. 183:2669-74
289. Gorelik L, Constant S, Flavell RA. 2002. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195:1499-505
290. Lafaille JJ. 1998. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 9:139-51
291. Almawi WY, Tamim H, Azar ST. 1999. Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J. Clin. Endocrinol. Metab. 84:1497-502
292. Casares S, Brumeanu TD. 2001. Insights into the pathogenesis of type 1 diabetes: a hint for novel immunospecific therapies. Curr. Mol. Med. 1:357-78
293. Stassi G, Di Liberto D, Todaro M, Zeuner A, Ricci-Vitiani L, et al. 2000. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins. Nat. Immunol. 1:483-88
294. Theofilopoulos AN, Koundouris S, Kono DH, Lawson BR. 2001. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res. 3:136-41
295. Akahoshi M, Nakashima H, Tanaka Y, Kohsaka T, Nagano S, et al. 1999. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheumatol. 42:1644-48
296. Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T et al. 2001. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheumatol. 44:2097-106
297. Holz A, Bot A, Coon B, Wolfe T, Grusby MJ, von Herrath MG. 1999. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence. J. Immunol. 163:5374-82
298. Nakazawa T, Satoh J, Takahashi K, Sakata Y, Ikehata F, et al. 2001. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1. J. Autoimmun. 17:119-25
299. Karlsen AE, Ronn SG, Lindberg K, Johannesen J, Galsgaard ED, et al. 2001. Suppressor of cytokine signaling 3 (SOCS-3) protects beta cells against interleukin-1beta- and interferon-gamma-mediated toxicity. Proc. Natl. Acad. Sci. USA 98:12191-96
300. Rothe H, Hausmann A, Casteels K, Okamura H, Kurimoto M, et al. 1999. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. J. Immunol. 163:1230-36
301. Trembleau S, Penna G, Gregori S, Chapman HD, Serreze DV, et al. 1999. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J. Immunol. 163:2960-68
302. Wong CK, Li EK, Ho CY, Lam CW. 2000. Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 39:1078-81
303. Esfandiari E, McInnes IB, Lindop G, Huang FP, Field M, et al. 2001. A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J. Immunol. 167:5338-47
304. Neumann D, Del Giudice E, Ciaramella A, Boraschi D, Bossu P. 2001. Lymphocytes from autoimmune MRL 1pr/1pr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain. J. Immunol. 166:3757-62
305. Peng SL, Moslehi J, Craft J. 1997. Roles of interferon-gamma and interleukin-4 in murine lupus. J. Clin. Invest. 99:1936-46
306. Balomenos D, Rumold R, Theofilopoulos AN. 1998. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-1pr mice. J. Clin. Invest. 101:364-71
307. Haas C, Ryffel B, Le Hir M. 1998. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis inlupus-prone(NZB x NZW)F1 mice. J. Immunol. 160:3713-18
308. Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, et al. 2000. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-1pr/1pr mice. Eur. J. Immunol. 30:438-47
309. Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR. 1998. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(1pr) mice. J. Immunol. 161:494-503
310. Nakajima A, Hirose S, Yagita H, Okumura K. 1997. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J. Immunol. 158:1466-72
311. Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, et al. 1998. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheumatol. 41:838-44
312. Min DJ, Cho ML, Cho CS, Min SY, Kim WU, et al. 2001. Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus. Scand. J. Rheumatol. 30:159-63
313. Lauwerys BR, Garot N, Renauld JC, Houssiau FA. 2000. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arthritis Rheumatol. 43:1976-81